This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chouhan, V. D. Articles by Rao, A. K. Search for Related Content PubMed PubMed Citation Articles by Chouhan, V. D. Articles by Rao, A. K. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Deep Vein Thrombosis Related Collections Anticoagulant mechanisms Peripheral vascular disease Other Treatment

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2812.)
© 1999 American Heart Association, Inc.

Thrombosis

Inhibition of Tissue Factor Pathway During Intermittent Pneumatic Compression

A Possible Mechanism for Antithrombotic Effect

Vibhuti D. Chouhan; Anthony J. Comerota; Ling Sun; Russell Harada; John P. Gaughan; A. Koneti Rao

From the Department of Medicine, The Sol Sherry Thrombosis Research Center (V.D.C., L.S., A.K.R.), and the Departments of Surgery (A.J.C., R.H.), and Physiology (J.P.G.), Temple University School of Medicine, Philadelphia, Pa.

Correspondence to A. Koneti Rao, MD, Division of Hematology and Thromboembolic Diseases, Temple University School of Medicine, 3400 N Broad Street, OMS 300, Philadelphia, PA 19140. E-mail koneti{at}astro.ocis.temple.edu

Abstract—Intermittent pneumatic compression (IPC) devices are an effective prophylaxis against lower extremity deep vein thrombosis. Their antithrombotic effect has been attributed to a reduction in venous stasis and enhanced fibrinolysis. The initiating mechanism for blood coagulation is the tissue factor (TF) dependent pathway, which is inhibited by tissue factor pathway inhibitor (TFPI). We have investigated the effect of IPC on the TF pathway in 6 normal subjects and 6 patients with postthrombotic venous disease undergoing IPC for 120 minutes; all subjects were studied with each of 5 IPC devices. In normal subjects and patients, plasma factor VIIa (FVIIa) activity (the activated form of factor VII [FVII]) declined from mean values ranging 51 to 65 and 50 to 53 mU/mL before IPC with different devices to 10 to 13 and 20 to 22 mU/mL at 180 minutes, respectively (P<0.001 for all groups). FVII antigen levels were unchanged. Plasma TFPI (P<0.001) rose from mean baseline values ranging 69 to 79 and 57 to 61 ng/mL to 76 to 123 and 71 to 79 ng/mL at 180 minutes in normal subjects and patients, respectively (P<0.001 for all groups). Plasma prothrombin fragment F1.2 levels showed minimal changes. There was an inverse relationship between TFPI and FVIIa in normal subjects (r=-0.31, P=0.001) and patients (r=-0.37, P<0.001). IPC results in an increase in plasma TFPI and decline in FVIIa. Inhibition of TF pathway, the initiating mechanism of blood coagulation, is a possible mechanism for the antithrombotic effect of IPC.

Key Words: intermittent pneumatic compression • tissue factor pathway • factor VIIa • tissue factor pathway inhibitor • factor VII

This article has been cited by other articles:

				R. Eisele, L. Kinzl, and T. Koelsch Rapid-Inflation Intermittent Pneumatic Compression for Prevention of Deep Venous Thrombosis J. Bone Joint Surg. Am., May 1, 2007; 89(5): 1050 - 1056. [Abstract] [Full Text] [PDF]

				G. Dai, O. Tsukurov, M. Chen, J. P. Gertler, and R. D. Kamm Endothelial nitric oxide production during in vitro simulation of external limb compression Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2066 - H2075. [Abstract] [Full Text] [PDF]